Micrometastasis: Detection methods and clinical importance

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Biomarkers

• Publication date

  2011-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/CBM-2011-0161PMID 22112487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells

  2008cited by this paper
• Review: Biological relevance of disseminated tumor cells in cancer patients

  2008cited by this paper
• Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer.

  2008cited by this paper
• Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.

  2008cited by this paper
• Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.

  2008cited by this paper
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

  2008cited by this paper
• Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.

  2008cited by this paper
• A “class action” against the microenvironment: do cancer cells cooperate in metastasis?

  2008cited by this paper
• Prognostic Impact of Micrometastases in Colon Cancer: Interim Results of a Prospective Multicenter Trial

  2007cited by this paper
• Sentinel Lymph Node Biopsy in Colon Cancer: A Prospective Multicenter Trial

  2007cited by this paper
• Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.

  2007cited by this paper
• Detection of MAGE-A Transcripts in Bone Marrow Is an Independent Prognostic Factor in Operable Non–Small-Cell Lung Cancer

  2007cited by this paper
• Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Prospective Randomized Study Comparing Sentinel Lymph Node Evaluation With Standard Pathologic Evaluation for the Staging of Colon Carcinoma: Results From the United States Military Cancer Institute Clinical Trials Group Study GI-01

  2007cited by this paper
• Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

  2007cited by this paper
• Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

  2007cited by this paper
• Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.

  2007cited by this paper
• Epithelial Molecular Markers in the Peripheral Blood of Patients with Colorectal Cancer

  2007cited by this paper
• The Impact of Immunohistochemical Detection of Positive Lymph Nodes in Early Stage Lung Cancer

  2006cited by this paper
• Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non–Small Cell Lung Cancer Patients

  2006cited by this paper
• Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist

  2006cited by this paper
• Chemotherapy and Radiotherapy in the Treatment of Resectable Non–Small-Cell Lung Cancer

  2006cited by this paper
• Multimarker RT–PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients

  2006cited by this paper
• Monitoring of disseminated tumor cells in bone marrow in high‐risk breast cancer patients treated with high‐dose chemotherapy

  2006cited by this paper
• CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells

  2006cited by this paper
• High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer

  2006cited by this paper
• Staging of colon and rectal cancer: from endoscopy to molecular markers

  2006cited by this paper
• A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

  2006cited by this paper
• Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.

  2006cited by this paper
• Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases.

  2006cited by this paper
• p53 and breast cancer, an update.

  2006cited by this paper
• Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

  2005cited by this paper
• Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques

  2005cited by this paper
• Circulating and disseminated tumor cells.

  2005cited by this paper
• Quantum dots in bio-imaging: Revolution by the small.

  2005cited by this paper
• Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR.

  2005cited by this paper
• Quantitative real-time RT-PCR--a perspective.

  2005cited by this paper
• Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years

  2005cited by this paper
• Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

  2005cited by this paper
• Re: Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30(8):807-16.

  2005cited by this paper
• APC, K-ras, and p53 Gene Mutations in Colorectal Cancer Patients: Correlation to Clinicopathologic Features and Postoperative Surveillance

  2005cited by this paper
• Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer.

  2005cited by this paper
• Cancer of the prostate.

  2005cited by this paper
• Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.

  2005cited by this paper
• Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.

  2005cited by this paper
• Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?

  2005cited by this paper
• Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance

  2005cited by this paper
• Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.

  2005cited by this paper
• Global gene expression profiling of circulating tumor cells.

  2005cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005influential reference
• Frequent EpCam protein expression in human carcinomas.

  2004cited by this paper
• Development of a rare cell fractionation device: application for cancer detection

  2004cited by this paper
• CD44 Potentiates the Adherence of Metastatic Prostate and Breast Cancer Cells to Bone Marrow Endothelial Cells

  2004cited by this paper
• Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.

  2004cited by this paper
• A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule‐positive cells in bone marrow from patients with breast carcinoma

  2004cited by this paper
• Real-time RT–PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer

  2004cited by this paper
• Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Quantitative real‐time RT‐PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers

  2004cited by this paper
• Dissecting the metastatic cascade

  2004cited by this paper
• Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation.

  2004cited by this paper
• Molecular Detection of Micrometastatic Breast Cancer in Histopathology-Negative Axillary Lymph Nodes Correlates With Traditional Predictors of Prognosis: An Interim Analysis of a Prospective Multi-Institutional Cohort Study

  2004cited by this paper
• Circulating tumour cells in breast cancer.

  2004cited by this paper
• Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance

  2004cited by this paper
• Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

  2004cited by this paper
• Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage

  2004cited by this paper
• The clinical significance of axillary lymph node micrometastases in breast cancer.

  2004cited by this paper
• Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer.

  2003cited by this paper
• From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

  2003cited by this paper
• Occult metastases: real harm or false alarm?

  2003cited by this paper
• Molecular profiling of single cells and tissue specimens with quantum dots.

  2003cited by this paper
• Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• DNA methylation in serum of breast cancer patients: an independent prognostic marker.

  2003cited by this paper
• Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

  2003cited by this paper
• Bone metastases in breast cancer

  2003cited by this paper
• Clinical Relevance of Reverse Transcriptase-Polymerase Chain Reaction for the Detection of Axillary Lymph Node Metastases in Breast Cancer

  2003cited by this paper
• Cancer of the prostate

  2003cited by this paper
• Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood.

  2002cited by this paper
• Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

  2002cited by this paper
• Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.

  2002cited by this paper
• Detection of circulating breast tumor cells by differential expression of marker genes.

  2002cited by this paper
• Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer.

  2002cited by this paper
• Real-time PCR technology for cancer diagnostics.

  2002cited by this paper
• Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells

  2002cited by this paper
• Combined transcriptome and genome analysis of single micrometastatic cells

  2002cited by this paper
• Minimal residual disease in non-small-cell lung cancer.

  2001cited by this paper
• Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panel

  2001cited by this paper
• Transcriptional Complementarity in Breast Cancer: Application to Detection of Circulating Tumor Cells

  2001cited by this paper
• ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.

  2001cited by this paper
• Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer

  2001cited by this paper
• Detection of Cytokeratin-Positive Cells in Bone Marrow in Breast Cancer and Colorectal Carcinoma in Comparison with Other Factors of Prognosis

  2000cited by this paper
• Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.

  2000cited by this paper
• Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.

  2000cited by this paper
• CD44 expression and regulation during mammary gland development and function.

  2000cited by this paper
• Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging.

  2000cited by this paper

• Histopathological assessment to detect colorectal ovarian micrometastasis following prophylactic salpingo-oophorectomy in postmenopausal patients

  2026cites this paper
• Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial

  2025cites this paper
• Computed DWI MRI Results in Superior Capability for N‐Stage Assessment of Non‐Small Cell Lung Cancer Than That of Actual DWI, STIR Imaging, and FDG‐PET/CT

  2022cites this paper
• Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach

  2021cites this paper
• The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review.

  2019cites this paper
• Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation

  2018cites this paper
• Signal transducer and activator of transcription 3 overexpression promotes lymph node micrometastasis in early‐stage non‐small cell lung cancer

  2018cites this paper
• Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis

  2018cites this paper
• Imaging and scopes? It's bloody time for another branch in the decision tree.

  2018cites this paper
• Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program

  2018cites this paper
• Sensitive molecular detection of small nodal metastasis in uterine cervical cancer using HPV16-E6/CK19/MUC1 cancer biomarkers

  2018cites this paper
• Detektion und Topographie disseminierter Tumorzellen in Lymphknoten bei Prostatakrebspatienten mittels quantitativer Polymerasekettenreaktion und Nachweis des Markers Kallikrein 4

  2018cites this paper
• 非小细胞肺癌淋巴结微转移的研究进展

  2018cites this paper
• Lymphatic micrometastases predict biochemical recurrence in patients undergoing radical prostatectomy and pelvic lymph node dissection for prostate cancer

  2018cites this paper
• Breast Cancer Biomarkers in Circulation

  2017cites this paper
• Chapter 2 The Metastatic Microenvironment

  2017cites this paper
• PHOX2B is a suppressor of neuroblastoma metastasis

  2016cites this paper
• Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer

  2016cites this paper
• CTC Analysis: FISH, ISH, Array-CGH, and Other Molecular Assays

  2016influential citation
• Circulating Tumor Cells: Enrichment and Genomic Applications

  2015cites this paper
• Détection moléculaire des métastases des ganglions lymphatique dans le cancer du col de l'utérus

  2015cites this paper
• The role played by the microenvironment in site-specific metastasis.

  2014cites this paper
• Micrometastasis in head and neck squamous cell carcinoma.

  2014cites this paper
• Göğüs Kanserinde Flow Sitometri ile Tespit Edilenen Kemik İliği Mikrometastazının Kemik, Kemik İliği, ve Akciğer Makrometastazları ile İlişkilidir

  2014cites this paper
• Biophysics of Cancer: Cellular Excitability (“CELEX”) Hypothesis of Metastasis

  2014cites this paper
• Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer.

  2014cites this paper
• Disseminating breast cancer stem cells and their molecular characterization

  2013cites this paper
• Clinical significance of disseminated tumour cells in non-small cell lung cancer

  2013influential citation
• Sensitive antibody-based CTCs detection from peripheral blood

  2013cites this paper
• Current challenges in metastasis: Disseminated and circulating tumor cells detection

  2013cites this paper
• The Metastatic Microenvironment

  2013cites this paper
• Individual detection significances of small breast epithelial mucin (SBEM) and human mammaglobin (hMAM) expressions in peripheral blood of breast cancer patients

  2012cites this paper
• Clinical Implications of Circulating Tumor Cells in Advanced Colorectal Cancer

  2012cites this paper
• Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment

  2012cites this paper
• Novas perspectivas para a Biologia do Câncer: Compreendendo as metástases.

  2012cites this paper
• Prevalência de Doenças não Transmissíveis, Risco para Doença Cardiovascular e Estado Nutricional em Idosos que Participam de um Grupo da Terceira Idade em Maringá - Pr

  2012cites this paper